Peripartum cardiomyopathy: An update

Progress in Pediatric Cardiology

Volumn 25, Issue 1, 2008, Pages 79-84

  Fisher, Stacy D ^a   Etherington, Amena ^a   Schwartz, David B ^a   Pearson, Gail D ^b  

^a SINAI HOSPITAL OF BALTIMORE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Apoptosis; Heart failure; Peripartum cardiomyopathy

Indexed keywords

BROMOCRIPTINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LEVOSIMENDAN;

AFRICAN AMERICAN; ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CARDIOMYOPATHY; CONVALESCENCE; DELIVERY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ECHOCARDIOGRAPHY; HEART FAILURE; HEART VENTRICLE; HUMAN; INTROSPECTION; MORBIDITY; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PERIPARTUM CARDIOMYOPATHY; PREDICTION; PREGNANCY; PREGNANCY DISORDER; PRIORITY JOURNAL; PROGNOSIS;

EID: 40949088980     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ppedcard.2007.11.009     Document Type: Article

References (42)

1. Pearson G.D., Veille J.C., Rahimtoola S., et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 283 9 (2000) 1183-1188
2. Abboud J., Murad Y., Chen-Scarabelli C., et al. Peripartum cardiomyopathy: a comprehensive review. Int J Cardiol 118 3 (2007) 295-303
3. Sliwa K., Fett J., and Elkayam U. Peripartum cardiomyopathy. Lancet 368 9536 (2006) 687-693
4. Ro R.A., and Frishman W.H. Peripartum cardiomyopathy. Cardiol Rev 14 1 (2006) 35-42
5. Elkayam U., Akhter M.W., Singh H., et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 111 16 (2005) 2050-2055
6. Mielniczuk L.M., Williams K., Davis D.R., et al. Frequency of peripartum cardiomyopathy. Am J Cardiol 97 12 (2006) 1765-1768
7. Brar S.S., Khan S.S., Sandhu G.K., et al. Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol 100 2 (2007) 302-304
8. Martin J.A., Hamilton B.E., Sutton P.D., et al. Births: final data for 2004. Natl Vital Stat Rep 55 1 (2006) 1-101
9. Fett J.D., Christie L.G., Carraway R.D., and Murphy J.G. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc 80 12 (2005) 1602-1606
10. Sakata Y., Hoit B.D., Liggett S.B., et al. Decompensation of pressure-overload hypertrophy in Gαq-overexpressing mic. Circulation 97 15 (1998) 1433-1435
11. Hayakawa Y., Chandra M., Miao W., et al. Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Gq transgenic mic. Circulation 108 24 (2003) 3036-3041
12. Kunisada K., Tone E., Fujio Y., et al. Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. Circulation 98 4 (1998) 346-352
13. Hilfiker-Kleiner D., Kaminski K., Podewski E., et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 128 3 (2007) 589-600
14. Podewski E.K., Hilfiker-Kleiner D., Hilfiker A., et al. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy. Circulation 107 6 (2003) 798-802
15. Sliwa K., Forster O., Libhaber E., et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 27 4 (2006) 441-446
16. Demakis J.G., Rahimtoola S.H., Sutton G.C., et al. Natural course of peripartum cardiomyopathy. Circulation 44 6 (1971) 1053-1061
17. Hibbard J.U., Lindheimer M., and Lang R.M. A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol 94 2 (1999) 311-316
18. Wake K., Takanishi T., Kitajima T., et al. Cardiac arrest during emergency cesarean section due to peripartum cardiomyopathy-a case report. Masui 52 10 (2003) 1089-1091
19. Fussell K.M., Awad J.A., and Ware L.B. Case of fulminant hepatic failure due to unrecognized peripartum cardiomyopathy. Crit Care Med 33 4 (2005) 891-893
20. Lui C.Y., Marcus F.I., and Sobonya R.E. Arrhythmogenic right ventricular dysplasia masquerading as peripartum cardiomyopathy with atrial flutter, advanced atrioventricular block and embolic stroke. Cardiology 97 1 (2002) 49-50
21. Patel C., Shirali G., and Pereira N. Left ventricular noncompaction mimicking peripartum cardiomyopathy. J Am Soc Echocardiogr 20 8 (2007) 1009.e9-1009.e12
22. Lipshultz S.E., Colan S.D., Gelber R.D., et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 324 12 (1991) 808-815
23. Steinherz L.J., Steinherz P.G., Tan C.T., et al. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 266 12 (1991) 1672-1677
24. Adams M.J., and Lipshultz S.E. Pathophysiology of anthracycline-and radiation-associated cardiomyopathies: implications for screening and prevention. Pediatr Blood Cancer 44 7 (2005) 600-606
25. Berry G.J., and Jordan M. Pathology of radiation and anthracycline cardiotoxicity. Pediatr Blood Cancer 44 7 (2005) 630-637
26. Gonzalez A., Fortuno M.A., and Querejeta R. Cardiomyocyte apoptosis in hypertensive cardiomyopathy. Cardiovasc Res 59 3 (2003) 549-562
27. Benlolo S., Lefoll C., Katchatouryan V., et al. Successful use of levosimendan in a patient with peripartum cardiomyopathy. Anesth Analg 98 3 (2004) 822-824
28. Benezet-Mazuecos J., and de la Hera J. Peripartum cardiomyopathy: a new successful setting for levosimendan. Int J Cardiol (2007) [Electronic publication ahead of print]
29. Tandler R., Schmid C., Weyand M., and Scheld H.H. Case report: Novacor LVAD bridge to transplantation in peripartum cardiomyopathy. Eur J Cardio-thorac Surg 11 (1997) 394-396
30. Yang H.S., Hong Y.S., Rim S.J., and Yu S.H. Extracorporeal membrane oxygenation in a patient with peripartum cardiomyopathy. Ann Thorac Surg 84 (2007) 262-264
31. Whitehead S.J., Berg C.J., and Chang J. Pregnancy-related mortality due to cardiomyopathy: United States, 1991-1997. Obstet Gynecol 102 6 (2003) 1326-1331
32. Shariff S., and Zaman K.S. Prognostic factors at initial presentation in patients with peripartum cardiomyopathy. J Pak Med Assoc 53 (2003) 297
33. Chapa J.B., Heiberger H.B., Weinert L., et al. Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol 105 6 (2005) 1303-1308
34. Amos A.M., Jaber W.A., and Russell S.D. Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J 152 3 (2006) 509-513
35. Box L.C., Hanak V., and Arciniegas J.G. Dual coronary emboli in peripartum cardiomyopathy. Texas Heart Inst J 31 4 (2004) 442-444
36. Dorbala S., Brozena S., Logsetty G., et al. Risk stratification of women with peripartum cardiomyopathy at initial presentation: a dobutamine stress echocardiography study. J Am Soc Echocardiogr 18 1 (2005) 45-48
37. Hu C.L., Li Y.B., Zou Y.G., et al. Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy. Heart 93 4 (2007) 488-490
38. Elkayam U., Tummala P.P., Rao K., et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 344 21 (2001) 1567-1571
39. Fett J.D., and Murphy J.G. Infant survival in Haiti after maternal death from peripartum cardiomyopathy. Int J Gynecol Obstet 94 (2006) 135-136
40. Romero R., Espinoza J., Kusanovic J.P., et al. The role of inflammation and infection in preterm birth. Semin Reprod Med 25 1 (2007) 21-39
41. Lipshultz S.E., Easley K.A., Orav E.J., et al. Cardiovascular status of infants and children of women infected with HIV-1 (P(2)C(2) HIV): a cohort study. Lancet 360 9330 (2002) 368-373
42. Safirstein J.G., Ro A.S., Grandhi S., et al. Evaluation of classic risk factors in a new cohort of peripartum cardiomyopathy survivors. J Card Fail 13 6 Suppl (2007) S154